TERRACCIANO, Stefania
 Distribuzione geografica
Continente #
AS - Asia 6.995
NA - Nord America 3.088
EU - Europa 1.122
SA - Sud America 233
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 11.458
Nazione #
HK - Hong Kong 6.018
US - Stati Uniti d'America 3.024
SG - Singapore 411
IT - Italia 347
CN - Cina 302
BR - Brasile 197
RU - Federazione Russa 187
DE - Germania 164
UA - Ucraina 141
VN - Vietnam 71
IE - Irlanda 62
TR - Turchia 60
SE - Svezia 53
FI - Finlandia 51
GB - Regno Unito 41
CA - Canada 40
KR - Corea 35
IN - India 29
JP - Giappone 22
MX - Messico 17
NL - Olanda 16
PL - Polonia 14
AR - Argentina 13
CZ - Repubblica Ceca 12
ES - Italia 10
AT - Austria 9
ID - Indonesia 9
BD - Bangladesh 8
ZA - Sudafrica 8
AZ - Azerbaigian 6
UZ - Uzbekistan 6
CO - Colombia 5
PK - Pakistan 5
EC - Ecuador 4
AE - Emirati Arabi Uniti 3
EG - Egitto 3
GT - Guatemala 3
IQ - Iraq 3
LT - Lituania 3
PY - Paraguay 3
RO - Romania 3
VE - Venezuela 3
BG - Bulgaria 2
CH - Svizzera 2
CL - Cile 2
DO - Repubblica Dominicana 2
EU - Europa 2
FR - Francia 2
IL - Israele 2
MA - Marocco 2
PE - Perù 2
PH - Filippine 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
GF - Guiana Francese 1
GY - Guiana 1
HU - Ungheria 1
KE - Kenya 1
KZ - Kazakistan 1
LC - Santa Lucia 1
NG - Nigeria 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PW - Palau 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 11.458
Città #
Hong Kong 6.006
Ann Arbor 579
Dallas 323
Chandler 306
Woodbridge 236
Jacksonville 173
Wilmington 170
Singapore 167
Princeton 166
Houston 156
Ashburn 148
Salerno 93
Beijing 63
Dublin 60
Munich 59
Izmir 53
Nanjing 45
Andover 35
Los Angeles 35
New York 33
Naples 31
Boardman 30
Dearborn 29
Pellezzano 28
Moscow 24
Turku 24
Montreal 22
Tokyo 22
Fisciano 20
Redwood City 17
São Paulo 17
Guangzhou 16
Fairfield 15
Ho Chi Minh City 15
Brooklyn 14
Columbus 14
Nuremberg 14
Boston 13
Hanoi 13
The Dalles 13
Dong Ket 12
Jiaxing 12
Warsaw 12
Changsha 11
Denver 11
Hebei 11
Orem 11
Stockholm 11
Brno 10
Nanchang 9
Phoenix 9
Seattle 9
Atlanta 8
Chennai 8
Chicago 8
Düsseldorf 8
Johannesburg 8
Mestre 8
Mexico City 8
Shenyang 8
Washington 8
Belo Horizonte 7
London 7
Manchester 7
Norwalk 7
Pune 7
San Francisco 7
Santa Clara 7
Charlotte 6
Ottawa 6
Amsterdam 5
Ankara 5
Baku 5
Caianello 5
Chandigarh 5
Curitiba 5
Falls Church 5
Jinan 5
Nürnberg 5
Arzano 4
Campinas 4
Council Bluffs 4
Hải Dương 4
Jakarta 4
Nocera Superiore 4
Pignola 4
Pomigliano d'Arco 4
Porto Alegre 4
Pozzuoli 4
Recife 4
San Diego 4
Seoul 4
Tashkent 4
Tianjin 4
Yubileyny 4
Chengdu 3
Cormano 3
Da Nang 3
Des Moines 3
Dhaka 3
Totale 9.682
Nome #
A Combinatorial Virtual Screening Approach Driving the Synthesis of 2,4-Thiazolidinedione-Based Molecules as New Dual mPGES-1/5-LO Inhibitors 1.102
Inhibition of Microsomal Prostaglandin E2 Synthase 1: focused design of new anti-inflammatory and anti-cancer drugs 915
Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition 612
Protein Preparation Automatic Protocol for High-Throughput Inverse Virtual Screening: Accelerating the Target Identification by Computational Methods 577
40 th "A. Corbella" International Summer School on Organic Synthesis - ISOS 2015 564
Chemistry and biology of anti-inflammatory marine natural products: molecules interfering with cyclooxygenase, NF-κB and other unidentified targets 515
Design, Synthesis, and Biological Activity of Hydroxamic Tertiary Amines as Histone Deacetylase Inhibitors 506
In Silico Design, Chemical Synthesis, Biophysical and in Vitro Evaluation for the Identification of 1-Ethyl-1H-Pyrazolo[3,4-b]Pyridine-Based BRD9 Binders 500
Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign 374
Identification of the 2-Benzoxazol-2-yl-phenol Scaffold as New Hit for JMJD3 Inhibition 344
9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomain 226
Cyclic Peptoids as Mycotoxin Mimics: An Exploration of Their Structural and Biological Properties 180
From Natural Compounds to Bioactive Molecules through NMR and In Silico Methodologies 177
Can Small Chemical Modifications of Natural Pan-inhibitors Modulate the Biological Selectivity? the Case of Curcumin Prenylated Derivatives Acting as HDAC or mPGES-1 Inhibitors 175
Structural Insights for the Optimization of Dihydropyrimidin-2(1H)-one Based mPGES-1 Inhibitors 165
Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold 165
Structural basis for the design and synthesis of selective HDAC inhibitors 163
Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E2 synthase-1 enzyme (mPGES-1) 158
Dimeric and trimeric triazole based molecules as a new class of Hsp90 molecular chaperone inhibitors 148
Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors 142
New dihydropyrimidin-2(1H)-one based Hsp90 C-terminal inhibitors 140
Identification of novel microsomal prostaglandin E2 synthase-1 (mPGES-1) lead inhibitors from Fragment Virtual Screening 140
Design and Synthesis of cyclopeptide analogues of the potent Histone deacetylase inhibitor FR235222 133
Identification of Lead Compounds as Inhibitors of STAT3: Design, Synthesis and Bioactivity 133
Correction: Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors 133
Synthesis, Conformational Analysis, and Cytotoxicity of New Analogues of the Natural Cyclodepsipeptide Jaspamide 132
Design,virtual Screening and Synthesis of Potential Microsomal Prostaglandine E2 Synthase-1 (mPGES-1)Inhibitors 122
Identification of Honokiol-Based Scaffold to Design Tankyrase 1/2 Inhibitors by In Silico and In Vitro Studies 117
Targeting Microsomal Prostaglanding E2 Synthase 1 for the Development of new potential Anti-Inflammatory Drugs 117
Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1 117
Discovery of new potent molecular entities able to inhibit mPGES-1 115
Conformationally locked calixarene-based histone deacetylase inhibitors 111
Total Synthesis, NMR Solution Structure, and Binding Model of the Potent Histone Deacetylase Inhibitor FR235222 109
Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222 106
Hsp90 Activity Modulation by Plant Secondary Metabolites 106
Discovery and synthesis of the first selective BAG domain modulator of BAG3 as an attractive candidate for the development of a new class of chemotherapeutics 106
Identification of 2,4,5-trisubstituted-2,4-dihydro-3H-1,2,4-triazol-3-one-based small molecules as selective BRD9 binders 105
Chemistry and Biology of Anti-Inflammatory Marine Natural Products.Phospholipase A2 Inhibitors 104
Structure-Based Design of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors using a Virtual Fragment Growing Optimization Scheme 101
Synthesis of new mono and bis amides projected as potential histone deacetylase (HDAC) inhibitors 100
Critical Surveys Covering the Year 2004:Total Synthesis of Natural Products 96
Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain 95
A multidisciplinary functional proteomics-aided strategy as a tool for the profiling of a novel cytotoxic thiadiazolopyrimidone 94
2-Substituted 1,5-benzothiazepine-based HDAC inhibitors exert anticancer activities on human solid and acute myeloid leukemia cell lines 93
Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors 91
Glucopyranosylbianthrones from the Algerian Asphodelus tenuifolius: Structural Insights and Biological Evaluation on Melanoma Cancer Cells 89
Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222 86
Chemoproteomics Reveals USP5 (Ubiquitin Carboxyl-Terminal Hydrolase 5) as Promising Target of the Marine Polyketide Gracilioether A 86
Discovery of noscapine derivatives as potential β-tubulin inhibitors 83
Virtual screening of 3-(1H-1,2,3-triazol-1-yl)piperidine-2,6-dione-based compounds as new potential Cereblon modulators amenable for targeted protein degradation 80
Synthetic and pharmacological studies on new simplified analogues of the potent actin-targeting Jaspamide 79
Exploring the chemical space of functionalized [1,2,4]triazolo[4,3-a]quinoxaline-based compounds targeting the bromodomain of BRD9 77
Identification of the first-in-class dual inhibitor targeting BAG3 and HSP70 proteins to disrupt multiple chaperone pathways 74
Structural Refinement of 2,4-Thiazolidinedione Derivatives as New Anticancer Agents Able to Modulate the BAG3 Protein 72
Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders 67
Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation 62
Synthesis, solution structure, and bioactivity of six new simplified analogues of the natural cyclodepsipeptide jaspamide 60
Targeting mPGES-1 by a Combinatorial Approach: Identification of the Aminobenzothiazole Scaffold to Suppress PGE2Levels 51
Identification of a New Promising BAG3 Modulator Featuring the Imidazopyridine Scaffold 46
Identification of 2,4-Dinitro-Biphenyl-Based Compounds as MAPEG Inhibitors 39
Identification of 2-Aminoacyl-1,3,4-thiadiazoles as Prostaglandin E2 and Leukotriene Biosynthesis Inhibitors 27
Totale 11.602
Categoria #
all - tutte 28.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.811


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021232 0 0 0 0 39 21 40 4 59 7 36 26
2021/2022315 4 0 0 5 9 8 10 11 49 38 45 136
2022/2023641 52 73 18 106 65 121 5 67 81 0 35 18
2023/2024288 20 42 20 12 38 54 13 22 6 8 10 43
2024/2025951 30 7 6 43 28 80 230 65 129 47 123 163
2025/20267.254 1.665 2.574 2.414 314 287 0 0 0 0 0 0 0
Totale 11.602